Literature DB >> 31954712

Morning Myopic Shift and Glare in Advanced Fuchs Endothelial Corneal Dystrophy.

Niklas Loreck1, Werner Adler2, Sebastian Siebelmann1, Alexander C Rokohl1, Ludwig M Heindl1, Claus Cursiefen1, Björn O Bachmann1, Mario Matthaei3.   

Abstract

PURPOSE: Impaired subjective morning visual acuity with improvement of symptoms during the day is pathognomonic for corneal endothelial dysfunction in advanced Fuchs endothelial corneal dystrophy (FECD). This study aimed to analyze the daily fluctuations of corneal thickness, refraction, and (glare) visual acuity in advanced FECD.
DESIGN: Prospective cohort study.
METHODS: Patients with advanced FECD (FECD group) and patients with normal cornea (control group) were enrolled. Routine clinical examination was performed using slit-lamp biomicroscopy, funduscopy, and macular optical coherence tomography. In addition, assessment using corneal Scheimpflug tomography (Pentacam), refraction, corrected distance visual acuity (CDVA), and glare CDVA was performed at 4 PM (afternoon) and the following day at 8 AM (morning).
RESULTS: A total of 29 FECD eyes and 22 control eyes were included. Diurnal variations from afternoon to morning were Δ corneal thickness (apex) ± standard deviation (SD) 41.45 ± 34.1 μm (P < .001, FECD group) and 5.5 ± 6.72 μm (P = .001, control group); Δ spherical equivalent ± SD -0.64 ± 0.6 diopters (D) (P < .001, FECD group) and -0.01 ± 0.50 D (P = .461, control group); Δ total corneal refractive power ± SD 0.60 ± 0.83 D (P = .001, FECD group) and -0.01 ± 0.49 D (P = .602, control group), Δ CDVA ± SD 0.15 ± 0.18 logarithm of minimal angle of resolution (logMAR) (P < .001, FECD group) and 0.02 ± 0.04 logMAR (P = .174, control group), Δ CDVA glare ± SD 0.34 ± 0.25 logMAR (P < .001, FECD group) and 0.05 ± 0.11 logMAR (P = .106, control group).
CONCLUSION: A morning myopic shift and increased glare paralleling increased corneal thickness may particularly contribute to subjective visual impairment in advanced FECD in the first hours after awaking. This should be taken into account during assessment and surgical decision-making in patients with FECD.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Year:  2020        PMID: 31954712     DOI: 10.1016/j.ajo.2020.01.011

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  3 in total

1.  Correlation of Clinical Fibrillar Layer Detection and Corneal Thickness in Advanced Fuchs Endothelial Corneal Dystrophy.

Authors:  Orlando Özer; Mert Mestanoglu; Antonia Howaldt; Thomas Clahsen; Petra Schiller; Sebastian Siebelmann; Niklas Reinking; Claus Cursiefen; Björn Bachmann; Mario Matthaei
Journal:  J Clin Med       Date:  2022-05-17       Impact factor: 4.964

2.  Corneal Analysis with Swept Source Optical Coherence Tomography in Patients with Coexisting Cataract and Fuchs Endothelial Corneal Dystrophy.

Authors:  Anna Nowińska; Edyta Chlasta-Twardzik; Michał Dembski; Klaudia Ulfik-Dembska; Edward Wylęgała
Journal:  Diagnostics (Basel)       Date:  2021-02-02

3.  Impact of DMEK on visual quality in patients with Fuchs' endothelial dystrophy.

Authors:  Vanessa Ademmer; Bishr Agha; Mehdi Shajari; Thomas Kohnen; Ingo Schmack
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2021-09-16       Impact factor: 3.535

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.